Unearthing the genotype‐inhibitor phenotype association in severe haemophilia A: A north Indian cohort study

Abstract

AbstractIntroductionVarious risk factors for inhibitor development in haemophilia A (HA) have been described but Indian data remains scanty.AimWe aimed to evaluate the genetic changes in Indian HA‐patients that are associated with the development of inhibitors.MethodsAll HA‐patients with inhibitors who availed coagulation‐laboratory services from January‐2015 till December‐2021 and had their samples preserved for DNA extraction were included in this study. An equal number of severity‐matched HA patients without inhibitors were also included as controls. Intron 22 and intron 1 inversions in Factor VIII gene were identified using inverse‐shifting‐PCR. Inversion‐negative patients were further assessed by targeted NGS, MLPA.ResultsThirty HA‐patients with inhibitors were identified. All had severe‐HA. Thirty severe‐HA‐patients without inhibitors were also included as controls. Intron 22 inversion (63.3%) and large deletions (15%) were the commonest variants identified. There was no difference in genetic variants in patients with low and high titre inhibitors. A3, A2 and C2 were the most common domains involved in inversion‐negative patients with inhibitors. However, there was no significant difference in domain involvement among inversion‐negative patients with and without inhibitors. Seven novel‐variants were identified, including three large deletions, one large duplication and two nonsense variants in inhibitor‐positive patients, and one frameshift variant in inhibitor‐negative patient. After adjusting for clinical risk‐factors, large deletions were independently associated with the presence of inhibitors [aOR:6.1 (1.41‐56.3)].ConclusionIntron 22 inversions are the commonest variant in Indian patients with severe‐HA. Large deletions predispose to inhibitor development independent of clinical risk factors.